FDA approves combination ibuprofen-acetaminophen drug for U.S. The ADA has long-advocated for OTC combination drug.
The Food and Drug Administration has approved the first over-the-counter ibuprofen and acetaminophen combination drug for the U.S.
The product—called Advil Dual Action—will be available nationwide later in 2020 and contains 250 mg of ibuprofen and 500 mg of acetaminophen, said GlaxoSmithKline, the drug’s manufacturer, in a news release.
The ADA has long advocated for the development of a single strength-controlled acetaminophen-ibuprofen combination drug to be available over-the-counter for dental patients—particularly as the nation continues to battle the opioid epidemic.
Read the full ADA News release.